Market closed
Pfizer/$PFE
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Pfizer
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
Ticker
$PFE
Sector
Trading on
NYSE
Industry
Pharmaceuticals
Headquarters
Employees
81,000
ISIN
US7170811035
Website
Pfizer Metrics
BasicAdvanced
$127B
16.11
$1.38
0.50
$1.69
7.72%
Price and volume
Market cap
$127B
Beta
0.5
52-week high
$31.54
52-week low
$20.92
Average daily volume
54M
Dividend rate
$1.69
Financial strength
Current ratio
1.258
Quick ratio
0.88
Long term debt to equity
63.9
Total debt to equity
68.843
Dividend payout ratio (TTM)
121.49%
Interest coverage (TTM)
5.58%
Management effectiveness
Return on assets (TTM)
4.79%
Return on equity (TTM)
8.62%
Valuation
Price to earnings (TTM)
16.107
Price to revenue (TTM)
2.022
Price to book
1.4
Price to tangible book (TTM)
-3.95
Price to free cash flow (TTM)
11.256
Dividend yield (TTM)
7.59%
Forward dividend yield
7.72%
Growth
Revenue change (TTM)
11.65%
Earnings per share change (TTM)
-2,464.07%
3-year revenue growth (CAGR)
-12.25%
3-year earnings per share growth (CAGR)
-31.81%
3-year dividend per share growth (CAGR)
2.49%
What the Analysts think about Pfizer
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Pfizer stock.
Pfizer Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Pfizer Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Pfizer News
AllArticlesVideos
Dr. Scott Gottlieb: What to expect from President Trump's executive order to lower drug prices
CNBC Television·4 hours ago
Trump Declares War On Pharma Drug Pricing, But The Stocks Aren't Tanking - Yet
Seeking Alpha·4 hours ago
Pfizer, Eli Lilly, Other Pharma Stocks Fall as Trump Targets Lower Drug Prices
Barrons·9 hours ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Market closed
Upcoming events
Jun13
Pfizer
Dividend·Payment
$0.43Per share
FAQs
What’s the current market cap for Pfizer stock?
Pfizer (PFE) has a market cap of $127B as of May 12, 2025.
What is the P/E ratio for Pfizer stock?
The price to earnings (P/E) ratio for Pfizer (PFE) stock is 16.11 as of May 12, 2025.
Does Pfizer stock pay dividends?
Yes, the Pfizer (PFE) stock pays dividends to shareholders. As of May 12, 2025, the dividend rate is $1.69 and the yield is 7.72%. Pfizer has a payout ratio of 121.49% on a trailing twelve-month basis.
When is the next Pfizer dividend payment date?
The next Pfizer (PFE) dividend payment is scheduled for June 13, 2025.
What is the beta indicator for Pfizer?
Pfizer (PFE) has a beta rating of 0.5. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.